N,N-Bis-(2-hydroxyethyl)-carbaminsaeure-methylester | 34085-52-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N,N-Bis-(2-hydroxyethyl)-carbaminsaeure-methylester
• 英文别名: methyl N,N-bis(2-hydroxyethyl)carbamate
• CAS: 34085-52-4
• 化学式: C₆H₁₃NO₄
• 分子量: 163.174
• InChiKey: YWUFFWKNECXAOD-UHFFFAOYSA-N

物化性质

• 沸点：
  297.6±33.0 °C(Predicted)
• 密度：
  1.223±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -1.2
• 重原子数：
  11
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  70
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N,N-Bis-(2-hydroxyethyl)-carbaminsaeure-methylester 在 咪唑 、 nickel(II) iodide 、 2,2'-联吡啶 、 溴 、 三苯基膦 、 锌 作用下， 以 二氯甲烷 、 N,N-二甲基乙酰胺 为溶剂， 反应 16.0h， 生成 吡咯烷甲基氨基甲酸酯
  参考文献：
  名称：

  Nickel-Catalyzed Reductive Cyclization of Alkyl Dihalides

  摘要：

  The reductive coupling protocol to intra-molecular cyclization of dihaloalkanes is presented. It leads to five- and six-membered rings, with the former being more efficient. The incorporation of secondary alkyl halides generally promotes coupling, efficiency. To the best of our know ledge this is the first catalytic ring closure reaction arising form dihaloalkanes under chemical reductive conditions.

  DOI：

  10.1021/ol502207z

文献信息

• [EN] MTORC MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE MTORC ET LEURS UTILISATIONS
  申请人：AEOVIAN PHARMACEUTICALS INC

  公开号：WO2020154447A1

  公开（公告）日：2020-07-30

  Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.

  本文披露了新型雷帕霉素类似物及其用途。本公开的雷帕霉素类似物相对于雷帕霉素表现出增加的mTORC1特异性和降低的mTORC2特异性。
• METHOD FOR PREPARING OPTICALLY ACTIVE PIPERIDINE COMPOUNDS
  申请人：Matsumae Hiroaki

  公开号：US20090198052A1

  公开（公告）日：2009-08-06

  The present invention relates to a method for preparing a syn-form piperidine compound represented by general formula [I]: wherein, bold lines represent bonds in which substituents at positions 2 and 4 of a piperidine ring are in the syn configuration, and the other symbols have the same meaning as defined below, or a salt thereof, comprising: reducing a compound represented by general formula [II]: wherein, ring A represents an optionally substituted benzene ring, R 2 represents a hydrogen atom, an optionally substituted hydroxyl group, an optionally substituted amino group, an optionally substituted alkyl group, a substituted carbonyl group or a halogen atom, and M represents an alkaline metal or hydrogen atom.

  本发明涉及一种制备一种由通式[I]表示的syn型哌啶化合物的方法：其中，粗线表示哌啶环的2和4位取代基处为syn构型，其他符号的含义如下所定义，或其盐，包括：还原由通式[II]表示的化合物：其中，环A表示可选取代的苯环，R2表示氢原子、可选取代的羟基、可选取代的氨基、可选取代的烷基、取代的羰基或卤素原子，M表示碱金属或氢原子。
• mTORC modulators and uses thereof
  申请人：Aeovian Pharmaceuticals, Inc.

  公开号：US11021492B2

  公开（公告）日：2021-06-01

  Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.

  本文公开了新型雷帕霉素类似物及其用途。 与雷帕霉素相比，本公开的雷帕霉素类似物显示出更高的 mTORC1 特异性和更低的 mTORC2 特异性。
• METHODS FOR THE PREPARATION OF AN N-BIS- 2-(1,2-DICARBOXY-ETHOXY)-ETHYL]AMINE DERIVATIVE AND PRODUCTS OF THE METHODS AND THEIR USES
  申请人：KEMIRA CHEMICALS OY

  公开号：EP1070045A1

  公开（公告）日：2001-01-24
• MTORC MODULATORS AND USES THEREOF
  申请人：Aeovian Pharmaceuticals, Inc.

  公开号：US20210002300A1

  公开（公告）日：2021-01-07

  Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.